<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00492479</url>
  </required_header>
  <id_info>
    <org_study_id>5314</org_study_id>
    <nct_id>NCT00492479</nct_id>
  </id_info>
  <brief_title>An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Innovative Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Innovative Medical</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen
      versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <condition>Skin Aging</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Kinerase Pro+Therapy Line day repair, serum, night repair</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Kinerase Pro+Therapy Line Ultra rich day repair</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LubriDerm</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients 35-55 years of age with at least moderate signs of facial aging

          -  Written informed consent

          -  Likely to complete all study visits and follow study protocol

        Exclusion Criteria:

          -  Any dermatological or medical condition which would make patient participation unsafe
             or interfere with study outcomes or measurements

          -  Known hypersensitivity to any study product or their components

          -  Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and
             other laser procedures)

          -  Prior use of anti-aging treatments for 30 days prior to study entry (physician
             dispensed or prescribed treatments)

          -  Planned facial procedures during the study (microdermabrasion, facials, etc)

             o Botox and fillers cannot be used during the trial or for 3 months prior to study
             entry

          -  Recent (within 60 days) or concurrent participation in another clinical trial

          -  Concomitant topical or systemic therapy that my interfere with study measurements or
             outcomes

          -  Use of any other topical photoaging/antiaging therapies during the study, other than
             the prescribed study regimens

          -  Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning
             during the study

          -  Wearing of cosmetics during study visits
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Steven Yoelin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Private Practice</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Steve Yoelin MD practice</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2007</study_first_submitted>
  <study_first_submitted_qc>June 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2007</study_first_posted>
  <last_update_submitted>December 18, 2007</last_update_submitted>
  <last_update_submitted_qc>December 18, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2007</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kinetin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

